Alerts will be sent to your verified email
Verify Email
PPLPHARMA
|
Piramal Pharma
|
Syngene Internation.
|
Laurus Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
15.43 % | n/a | n/a |
|
R&D as a % of Total Sales
|
0.69 % | n/a | 4.8 % |
|
Financials
|
|||
|
5 yr Average ROE
|
5.92 % | 15.0 % | 20.49 % |
|
5yr average Equity Multiplier
|
1.98 | 1.73 | 2.07 |
|
5yr Average Asset Turnover Ratio
|
0.53 | 0.5 | 0.76 |
|
5yr Avg Net Profit Margin
|
5.44 % | 17.38 % | 12.66 % |
|
Price to Book
|
2.58 | 6.42 | 5.86 |
|
P/E
|
0.0 | 53.57 | 150.16 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 2221.19 Days | 86.64 Days |
|
Inventory Days
|
66.26 Days | 14.46 Days | 104.93 Days |
|
Days Receivable
|
80.7 Days | 59.27 Days | 88.66 Days |
|
Days Payable
|
152.43 Days | -1300.22 Days | 140.44 Days |
|
5yr Average Interest Coverage Ratio
|
3.64 | 16.59 | 9.21 |
|
5yr Avg ROCE
|
7.05 % | 15.29 % | 24.83 % |
|
5yr Avg Operating Profit Margin
|
18.65 % | 33.22 % | 24.94 % |
|
5 yr average Debt to Equity
|
0.64 | 0.28 | 0.57 |
|
5yr CAGR Net Profit
|
n/a | 6.97 % | 52.94 % |
|
5yr Average Return on Assets
|
3.14 % | 8.62 % | 9.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.02 % | 54.79 % | 27.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.23 % | -15.79 % | -0.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
8.47 % | 8.65 % | 4.63 % |
|
Piramal Pharma
|
Syngene Internation.
|
Laurus Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Services Break-Up
|
Services Break-Up
|
-
|
-
|
